
Rebyte D 30mg/20mg Capsule SR
Marketer
Quria Healthcare
Salt Composition
Domperidone (30mg) + Rabeprazole (20mg)
Overview Rebyte D 30mg/20mg Capsule SR
Gastro-esophageal reflux disease (GERD, or acid reflux) can be managed with Rebyte D 30mg/20mg sustained-release capsules, a dual-action formulation. This medication alleviates acidity symptoms like heartburn, abdominal pain, and irritation by neutralizing stomach acid and facilitating gas expulsion, thus easing discomfort. Dosage and duration for Rebyte D 30mg/20mg SR capsules are determined by your physician, and should be taken on an empty stomach. Treatment adherence, as directed, is crucial; premature discontinuation might lead to symptom recurrence and condition exacerbation. Complete disclosure of all other medications to your healthcare provider is vital, as interactions may occur. Common, typically transient side effects include diarrhea, abdominal pain, dry mouth, headache, flatulence, and fatigue. However, any concerning side effects warrant immediate medical attention. Due to potential drowsiness and dizziness, avoid driving or activities requiring alertness until the medication's effects are known. Alcohol consumption should be avoided as it can increase drowsiness. Lifestyle adjustments, such as consuming cold milk and avoiding hot beverages, spicy foods, and chocolate, may enhance treatment outcomes. Prior to commencing treatment, inform your doctor of any pre-existing kidney or liver conditions, and if you are pregnant, planning pregnancy, or breastfeeding.
Uses of Rebyte D 30mg/20mg Capsule SR
Managing gastroesophageal reflux and peptic ulcers.
Major Benefits of Rebyte D 30mg/20mg Capsule SR:
Administer this medication precisely as prescribed by your physician, both in terms of dosage and treatment length. Ingest the capsule whole; avoid chewing, crushing, or fracturing it. Consume Rebyte D 30mg/20mg Extended-Release Capsules on an empty stomach.
Common Side effects of Rebyte D 30mg/20mg Capsule SR:
- Cough
- Headache
- Diarrhea
- Dizziness
- Inflammation of the nose
- Abdominal pain
- Vomiting
- Weakness
- Nasal congestion (stuffy nose)
- Insomnia (difficulty in sleeping)
- Fundic gland polyps
- Nausea
- Constipation
- Flatulence
- Back pain
- Pharyngitis
How to use Rebyte D 30mg/20mg Capsule SR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the entire capsule without chewing, crushing, or breaking it. Administer Rebyte D 30mg/20mg SR capsules on an empty stomach.
How Rebyte D 30mg/20mg Capsule SR works:
Rebyte D, a 30mg/20mg sustained-release capsule, unites Domperidone and Rabeprazole to address digestive issues. Domperidone, a prokinetic agent, enhances gastrointestinal motility, facilitating smoother food passage. Rabeprazole, a proton pump inhibitor (PPI), decreases stomach acid production, thereby alleviating acid indigestion and heartburn.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when combining Rebyte D 30mg/20mg SR capsules with alcohol. Seek medical advice before doing so.
PregnancyCONSULT YOUR DOCTOR
The use of Rebyte D 30mg/20mg SR Capsules during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Rebyte D 30mg/20mg capsule is likely unsuitable for breastfeeding mothers. Available human evidence indicates potential transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Taking Rebyte D 30mg/20mg sustained-release capsules might reduce awareness, impair vision, or cause drowsiness and dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Individuals with kidney impairment should exercise caution when using Rebyte D 30mg/20mg sustained-release capsules. Dosage modifications for Rebyte D 30mg/20mg sustained-release capsules may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should exercise caution when using Rebyte D 30mg/20mg sustained-release capsules. Dosage modification may be necessary. Physician consultation is advised. Rebyte D 30mg/20mg sustained-release capsules are contraindicated in individuals with moderate to severe hepatic dysfunction.
What if you forget to take Rebyte D 30mg/20mg Capsule SR :
Should you forget a Rebyte D 30mg/20mg sustained-release capsule, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Rebyte D 30mg/20mg Capsule SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
